BGI

BGI is a global biotechnology company specializing in research and development based on the study of genomics. It provides various entities and organizations with equipment, technical support, and solutions (such as precision medicine). The company was founded in 1999 and was initially established for the Human Genome Project.The company has more than 100one hundred locations worldwide in places such as China, Australia, the United States, South Africa, and the United Kingdom.

BGI was established for human genome research and still conducts that today. The company also conducts animal and plant, microbiology, and disease research as well asand research on universal sequencing.Eachsequencing. Each research area has specific projects that are being conductedundertaken. Some examples of projects in-progress as BGI are the International Thousand Human Genome Project, the Earth Biogenome Project, and the Million microbialMicrobiomes genomesfrom projectHumans Project (MMHP).

BGI provides clinical testing for areas such asincluding reproductive health and tumor prevention. It also provides In Vitro diagnostics for areas such as prepre- and post-natal testing. BGI has diagnostic services for judicial purposes as well includingand paternity testing.

BGI has developed multiple pieces of genomic sequencing equipment that are available for purchase, although they are unavailable in the United States, Spain, and Germany.ThereGermany. is also aA robotic ultrasound system that has been developed by BGI that can be purchased by appropriate parties.

In May 2022, reports startedbegan surfacing that there wasregarding an outbreak of the monkeypox virus spreading globally. By July 2022, the World Health Organization had declared monkeypox a public health emergency of international concern. BGI had developed a Monkeypox Virus Nucleic Acid Detection Kit (Fluorescent PCR), and it received European In-Vitro Diagnostic Devices Directive (CE-IVDD) approval, allowing for it to be used for testing in an attempt to curb the outbreak. The test uses the fluorescence PCR method to detect the MPV-1 gene and MPV-2 gene fragment of the monkeypox virus. Concerned parties can submit rash fluid, nasopharyngeal swabs, pharyngeal swabs, and serum samples for testtesting, and they get results in as little as 40forty minutes after the samples have been collected.

BGI is a global biotechnologybiotechnology company specializing in research and development based on the study of genomicsgenomics. It provides various entities and organizations with equipment, technical suportsupport, and solutions (such as precision medicine). The company was founded in 1999 and was initially established for the Human Genome ProjectHuman Genome Project.The company has more than 100 locations worldwide in places such as ChinaChina, AustraliaAustralia, the United StatesUnited States, South AfricaSouth Africa, and the United KingdomUnited Kingdom.

BGI was established for human genome research and still conducts that today. The company also conducts animal and plant, microbiology, and disease research as well as research on universal sequencing.Each research area has specific projects that are being conducted. Some examples of projects in-progress as BGI are the International Thousand Human Genome Project, the Earth Biogenome Project Earth Biogenome Project, and the Million microbial genomes project.

BGI provides clinical testing for areas such as reproductive health and tumor prevention.

BGI provides clinical testing for areas such as reproductive health and tumor prevention. It also provides In Vitro diagnostics for areas such as pre and post-natal testing. BGI has diagnostic services for judicial purposes as well including paternity testing.

BGI Desktop Sequencer

BGI has developed multiple pieces of genomic sequencing equipment that are available for purchase although they are unavailable in the United States, Spain, and Germany.There is also a robotic ultrasound system that has been developed by BGI that can be purchased by appropriate parties.

In May 2022, reports started surfacing that there was an outbreak of the monkeypox virus spreading globally. By July 2022, the World Health Organization had declared monkeypox a public health emergency of international concern. BGI had developed a Monkeypox Virus Nucleic Acid Detection Kit (Fluorescent PCR) and it received European In-Vitro Diagnostic Devices Directive (CE-IVDD) approval, allowing for it to be used for testing in an attempt to curb the outbreak. The test uses the fluorescence PCR method to detect the MPV-1 gene and MPV-2 gene fragment of the monkeypox virus. Concerned parties can submit rash fluid, nasopharyngeal swabs, pharyngeal swabs, and serum samples for test and get results in as little as 40 minutes after the samples have been collected.

BGI is a global biotechnology company specializing in research and development based on the study of genomics. It provides various entities and organizations with equipment, technical suport, and solutions (such as precision medicine). The company was founded in 1999 and was initially established for the Human Genome Project.The company has more than 100 locations worldwide in places such as China, Australia, the United States, South Africa, and the United Kingdom.

BGI offers a variety of products and services for the biotechnology industry. Below is more information for each of its offerings.

BGI was established for human genome research and still conducts that today. The company also conducts animal and plant, microbiology, and disease research as well as research on universal sequencing.Each research area has specific projects that are being conducted. Some examples of projects in-progress as BGI are the International Thousand Human Genome Project, the Earth Biogenome Project, and the Million microbial genomes project.

BGI provides clinical testing for areas such as reproductive health and tumor prevention.